A citation-based method for searching scientific literature

Logan Corey, Ana Valente, Katrina Wade. Surg Oncol Clin N Am 2020
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Poly(ADP-Ribose) polymerase promotes cardiac remodeling, contractile failure, and translocation of apoptosis-inducing factor in a murine experimental model of aortic banding and heart failure.
Chun-Yang Xiao, Min Chen, Zsuzsanna Zsengellér, Hongshan Li, Levente Kiss, Márk Kollai, Csaba Szabó. J Pharmacol Exp Ther 2005
85
100

Update on GLUT4 Vesicle Traffic: A Cornerstone of Insulin Action.
Javier R Jaldin-Fincati, Martin Pavarotti, Scott Frendo-Cumbo, Philip J Bilan, Amira Klip. Trends Endocrinol Metab 2017
124
100

PARP Inhibitor Protects Against Chronic Hypoxia/Reoxygenation-Induced Retinal Injury by Regulation of MAPKs, HIF1α, Nrf2, and NFκB.
Krisztina Kovacs, Alexandra Vaczy, Katalin Fekete, Petra Kovari, Tamas Atlasz, Dora Reglodi, Robert Gabriel, Ferenc Gallyas, Balazs Sumegi. Invest Ophthalmol Vis Sci 2019
18
100

The effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signals.
Seong-Ho Koh, Younjoo Park, Chi Won Song, Jun Gyou Kim, Kisok Kim, Juhan Kim, Myung-Ho Kim, Seung Ro Lee, Dong Won Kim, Hyun-Jeung Yu,[...]. Eur J Neurosci 2004
74
100


PARP inhibition attenuates acute kidney allograft rejection by suppressing cell death pathways and activating PI-3K-Akt cascade.
Karoly Kalmar-Nagy, Peter Degrell, Aliz Szabo, Katalin Sumegi, Istvan Wittmann, Ferenc Gallyas, Balazs Sumegi. PLoS One 2013
11
100

A change of view: homologous recombination at single-molecule resolution.
Kyle Kaniecki, Luisina De Tullio, Eric C Greene. Nat Rev Genet 2018
29
100

15
100

Improved poststorage cardiac function by poly (ADP-ribose) polymerase inhibition: role of phosphatidylinositol 3-kinase Akt pathway.
Ling Gao, Jair C Kwan, Peter S Macdonald, Lianxing Yang, Thomas Preiss, Mark Hicks. Transplantation 2007
11
100


ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells.
Stephanie A Yazinski, Valentine Comaills, Rémi Buisson, Marie-Michelle Genois, Hai Dang Nguyen, Chu Kwen Ho, Tanya Todorova Kwan, Robert Morris, Sam Lauffer, André Nussenzweig,[...]. Genes Dev 2017
161
100


Regulation of cell death protease caspase-9 by phosphorylation.
M H Cardone, N Roy, H R Stennicke, G S Salvesen, T F Franke, E Stanbridge, S Frisch, J C Reed. Science 1998
100

Angiotensin II-mediated endothelial dysfunction: role of poly(ADP-ribose) polymerase activation.
Csaba Szabó, Pál Pacher, Zsuzsanna Zsengellér, Anne Vaslin, Katalin Komjáti, Rita Benkö, Min Chen, Jon G Mabley, Márk Kollai. Mol Med 2004
67
100


A new, potent poly(ADP-ribose) polymerase inhibitor improves cardiac and vascular dysfunction associated with advanced aging.
Pál Pacher, Anne Vaslin, Rita Benko, Jon G Mabley, Lucas Liaudet, György Haskó, Anita Marton, Sándor Bátkai, Márk Kollai, Csaba Szabó. J Pharmacol Exp Ther 2004
68
100

Inhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death.
Sara Veto, Peter Acs, Jan Bauer, Hans Lassmann, Zoltan Berente, Gyorgy Setalo, Gabor Borgulya, Balazs Sumegi, Samuel Komoly, Ferenc Gallyas,[...]. Brain 2010
68
100

Survival kinases in ischemic preconditioning and postconditioning.
Derek J Hausenloy, Derek M Yellon. Cardiovasc Res 2006
389
100


PARP goes transcription.
W Lee Kraus, John T Lis. Cell 2003
428
100

PARP Inhibitor PJ34 Protects Mitochondria and Induces DNA-Damage Mediated Apoptosis in Combination With Cisplatin or Temozolomide in B16F10 Melanoma Cells.
Anna Maria Cseh, Zsolt Fabian, Ruben Quintana-Cabrera, Aliz Szabo, Krisztian Eros, Maria Eugenia Soriano, Ferenc Gallyas, Luca Scorrano, Balazs Sumegi. Front Physiol 2019
9
100


Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus.
Pengda Liu, Michael Begley, Wojciech Michowski, Hiroyuki Inuzuka, Miriam Ginzberg, Daming Gao, Peiling Tsou, Wenjian Gan, Antonella Papa, Byeong Mo Kim,[...]. Nature 2014
207
100

Activation of AKT kinases in cancer: implications for therapeutic targeting.
Alfonso Bellacosa, C Chandra Kumar, Antonio Di Cristofano, Joseph Robert Testa. Adv Cancer Res 2005
596
100

Poly(ADP-ribose) polymerases as modulators of mitochondrial activity.
Peter Bai, Lilla Nagy, Tamás Fodor, Lucas Liaudet, Pal Pacher. Trends Endocrinol Metab 2015
72
100

Dysregulation of AKT Pathway by SMYD2-Mediated Lysine Methylation on PTEN.
Makoto Nakakido, Zhenzhong Deng, Takehiro Suzuki, Naoshi Dohmae, Yusuke Nakamura, Ryuji Hamamoto. Neoplasia 2015
49
100


Cytoplasmic ATM protein kinase: an emerging therapeutic target for diabetes, cancer and neuronal degeneration.
Da-Qing Yang, Marie-Jo Halaby, Yan Li, Jody C Hibma, Paul Burn. Drug Discov Today 2011
67
100

PTEN: life as a tumor suppressor.
L Simpson, R Parsons. Exp Cell Res 2001
510
100

Fundamentals of cancer metabolism.
Ralph J DeBerardinis, Navdeep S Chandel. Sci Adv 2016
100

Akt2 expression correlates with prognosis of human hepatocellular carcinoma.
Xundi Xu, Masato Sakon, Hiroaki Nagano, Nobuaki Hiraoka, Hirofumi Yamamoto, Nobuyasu Hayashi, Keizo Dono, Shoji Nakamori, Koji Umeshita, Yasuhiro Ito,[...]. Oncol Rep 2004
90
100

Prospect for Application of PARP Inhibitor in Patients with HER2 Negative Breast Cancer.
Nan Shao, Yawei Shi, Liang Yu, Runyi Ye, Zhen Shan, Zhanqiang Zhang, Yunjian Zhang, Ying Lin. Int J Biol Sci 2019
7
100

Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB.
A Kauffmann-Zeh, P Rodriguez-Viciana, E Ulrich, C Gilbert, P Coffer, J Downward, G Evan. Nature 1997
100

A quinazoline-derivative compound with PARP inhibitory effect suppresses hypertension-induced vascular alterations in spontaneously hypertensive rats.
Klara Magyar, Laszlo Deres, Krisztian Eros, Kitti Bruszt, Laszlo Seress, Janos Hamar, Kalman Hideg, Andras Balogh, Ferenc Gallyas, Balazs Sumegi,[...]. Biochim Biophys Acta 2014
14
100

Inhibition of poly(ADP-ribose) glycohydrolase (PARG) specifically kills BRCA2-deficient tumor cells.
Catherine Fathers, Ross M Drayton, Svetlana Solovieva, Helen E Bryant. Cell Cycle 2012
60
100

AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis.
Hemant K Roy, Bola F Olusola, Dahn L Clemens, William J Karolski, Anne Ratashak, Henry T Lynch, Thomas C Smyrk. Carcinogenesis 2002
263
100


Cellular survival: a play in three Akts.
S R Datta, A Brunet, M E Greenberg. Genes Dev 1999
100

Physiological functions of protein kinase B/Akt.
Z-Z Yang, O Tschopp, A Baudry, B Dümmler, D Hynx, B A Hemmings. Biochem Soc Trans 2004
210
100

AKT as a Therapeutic Target for Cancer.
Mengqiu Song, Ann M Bode, Zigang Dong, Mee-Hyun Lee. Cancer Res 2019
170
100

Discovery and saturation analysis of cancer genes across 21 tumour types.
Michael S Lawrence, Petar Stojanov, Craig H Mermel, James T Robinson, Levi A Garraway, Todd R Golub, Matthew Meyerson, Stacey B Gabriel, Eric S Lander, Gad Getz. Nature 2014
100

Cardioprotective effect of KR-33889, a novel PARP inhibitor, against oxidative stress-induced apoptosis in H9c2 cells and isolated rat hearts.
Eun-Seok Park, Do-Hyun Kang, Jun Chul Kang, Yong Chang Jang, Min-Ju Lee, Hun-Jong Chung, Kyu Yang Yi, Dae-Eun Kim, Bokyung Kim, Hwa-Sup Shin. Arch Pharm Res 2017
11
100

Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors.
Jaeyul Kwon, Seung-Rock Lee, Kap-Seok Yang, Younghee Ahn, Yeun Ju Kim, Earl R Stadtman, Sue Goo Rhee. Proc Natl Acad Sci U S A 2004
467
100

Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling.
Christina Gewinner, Zhigang C Wang, Andrea Richardson, Julie Teruya-Feldstein, Dariush Etemadmoghadam, David Bowtell, Jordi Barretina, William M Lin, Lucia Rameh, Leonardo Salmena,[...]. Cancer Cell 2009
337
100

Mutations of the human PTEN gene.
D Bonneau, M Longy. Hum Mutat 2000
219
100


PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells.
Sylvie M Noordermeer, Haico van Attikum. Trends Cell Biol 2019
103
100

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.
S R Datta, H Dudek, X Tao, S Masters, H Fu, Y Gotoh, M E Greenberg. Cell 1997
100


PARP inhibitors: new tools to protect from inflammation.
Vincenzo Giansanti, Francesca Donà, Micol Tillhon, A Ivana Scovassi. Biochem Pharmacol 2010
64
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.